These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2834287

  • 1. [Expression of interleukin 2 receptors in in vivo Epstein-Barr virus transformed B lymphocytes].
    Becker H, Helmke K, Federlin K.
    Immun Infekt; 1988 Feb; 16(1):21-2. PubMed ID: 2834287
    [Abstract] [Full Text] [Related]

  • 2. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Feb; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 3. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R.
    Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
    [Abstract] [Full Text] [Related]

  • 4. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y, Tuaillon E, Jeziorski E, Ouedraogo DE, Bolloré K, Rubbo PA, Foulongne V, Rodière M, Vendrell JP.
    J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M, Kato M, Ikeno K, Kobayashi T, Miyagawa Y, Komiyama A, Akabane T.
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [Abstract] [Full Text] [Related]

  • 7. Role of T cell subpopulations in the control of the proliferative potential of EBV transformed B cells.
    Masucci MG, Klein E.
    Behring Inst Mitt; 1983 May; (72):163-8. PubMed ID: 6152688
    [No Abstract] [Full Text] [Related]

  • 8. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I, Sullivan JL, Periman PO, Perlin E.
    N Engl J Med; 1975 Dec 04; 293(23):1159-63. PubMed ID: 171568
    [Abstract] [Full Text] [Related]

  • 9. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
    Stuart AD, Stewart JP, Arrand JR, Mackett M.
    Oncogene; 1995 Nov 02; 11(9):1711-9. PubMed ID: 7478598
    [Abstract] [Full Text] [Related]

  • 10. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA.
    J Immunol; 1980 Feb 02; 124(2):745-51. PubMed ID: 6243331
    [Abstract] [Full Text] [Related]

  • 11. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 02; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 12. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
    Robinson JE.
    Yale J Biol Med; 1982 May 02; 55(3-4):311-6. PubMed ID: 6295008
    [Abstract] [Full Text] [Related]

  • 13. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.
    Matsushima K, Akahoshi T, Yamada M, Furutani Y, Oppenheim JJ.
    J Immunol; 1986 Jun 15; 136(12):4496-502. PubMed ID: 3011895
    [Abstract] [Full Text] [Related]

  • 14. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G, Magrath I, Koski I, Dooley N, Blaese M.
    N Engl J Med; 1979 Nov 22; 301(21):1133-7. PubMed ID: 226884
    [Abstract] [Full Text] [Related]

  • 15. Influence of Epstein-Barr virus infection on B lymphocyte responses in patients with rheumatoid arthritis.
    Becker HE, Vierbuchen C, Federlin K.
    J Autoimmun; 1989 Dec 22; 2(6):825-31. PubMed ID: 2559741
    [Abstract] [Full Text] [Related]

  • 16. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E.
    Cancer Res; 1981 Nov 22; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [Abstract] [Full Text] [Related]

  • 17. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
    Janssen O, Gillis S, Kabelitz D.
    Eur J Immunol; 1990 Jan 22; 20(1):7-14. PubMed ID: 2155117
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
    Yokoi T, Miyawaki T, Yachie A, Kato K, Kasahara Y, Taniguchi N.
    Immunology; 1990 May 22; 70(1):100-5. PubMed ID: 2162322
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
    Kurth J, Hansmann ML, Rajewsky K, Küppers R.
    Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4730-5. PubMed ID: 12665622
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms other than polyclonal B cell activation possibly involved in Epstein-Barr virus-induced autoimmunity.
    Garzelli C, Pacciardi A, Basolo F, Falcone G.
    Clin Exp Immunol; 1989 Jun 15; 76(3):412-6. PubMed ID: 2546702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.